Radiation Tissue Damage
Radiation is a commonly used treatment for many different medical conditions. It is frequently used as a therapy for various forms of cancer. It is common for radiation to cause necrosis (death of the cells), both cancerous and healthy, in the areas irradiated. The literature supports the effective use of Hyperbaric Oxygen Therapy for the treatment and resolution of symptoms of radiation necrosis regardless of the anatomical areas affected.
Radiation injury is common among individuals who have undergone radiation therapy in the treatment of prostate cancer. These patients experience symptoms of urinary incontinence, intermittent or constant hematuria, severe dysuria, pelvic or rectal pain, or even erectile dysfunction with the resulting radiation cystitis or prostatitis. Hyperbaric oxygen therapy is the only effective long lasting treatment for patients with radiation cystitis or radiation prostatitis. Click here to read more about hyperbaric oxygen therapy in treating these urological conditions.
Research & Studies
Long-term Incidence of Hematuria, Urethral Stricture & Bladder Cancer after Radiation Therapy for Prostate Cancer
Approximately 25% of patients diagnosed with prostate cancer choose radiation
therapy as the primary treatment for this malignancy. Urinary tract toxicity after rad iation therapy
impacts patients years after treatment of the malignancy.
Chronic Refractory Radiation Proctitis
Cancer patients who undergo radiotherapy remain at life-long risk of radiation-induced injury to normal tissues. R.E. Clarke et al. conducted a randomized, placebo controlled, double-blind crossover trial with long-term follow-up to evaluate the effectiveness of hyperbaric oxygen for refractory radiation proctitis.
Delayed Radiation Injury
More than 600,000 patients receive radiation for malignancy in the USA annually. HBOT has treated patients with radiation injury since mid-1970s, with published results that are consistently positive.
Hemorrhagic radiation cystitis (HRC)
Hemorrhagic radiation cystitis (HRC) is a significant clinical problem that occurs after pelvic radiation therapy and is often refractory. This study evaluates the efficacy and safety of hyperbaric oxygen therapy (HBOT) for HRC.
Radiation after Breast-Conserving Surgery
Hyperbaric Oxygen Therapy for late Sequelae in Women Receiving Radiation after Breast-Conserving Surgery
Delayed Radiation Injuries of the Extremities
Hyperbaric oxygen (HBOT) is used as an adjunct in the treatment of radiation injury at many sites, including then mandible, larynx, chest wall, bladder, and rectum. In these disorders, HBOT is effective in stimulating neovascularization and reducing fibrosis. This report is a retrospective, uncontrolled review of 17 patients, where HBOT was applied successfully with complete wound healing and the avoidance of amputation in a majority.